HLB Pharmaceutical

South Korea's pharmaceutical company Boryeong said on Friday that it held the first "Care-in-Space Challenge" event, a new space healthcare startup ...

DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight ye...

Daesang Welllife on Thursday said it has concluded a memorandum of understanding (MOU) with China Sinopharm International, an affiliate of China's l...

Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...

JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...

A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...

Biotechnology startups in Europe, backed by South Korea's SK Inc., are speeding up their development of next-generation drug candidates by joining h...

The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...

Overseas technology transfers from South Korean biotechs and pharmaceutical manufacturers this year have exceeded 11 trillion won ($9.3 billion), al...

Voronoi Inc., a South Korean biotechnology startup, has clinched a $324 million deal to grant Brickell Biotech, a US clinical-stage pharmaceutical f...

South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...

Celltrion Inc. and HLB Inc., two leading South Korean biopharmaceutical shares, shot up on Monday as the main bourse’s key index climbed back ...